Article
Mild neurodevelopmental disorder due to reduced SHMT2 enzymatic activity caused by novel compound heterozygous variants: expanding the phenotypic spectrum.
Neurogenetics - 26 Nov 2024
Pan Hu, He Mei, Luo Xuan, Hu Juanli, Mao Xiao, Cheng Yong, Liu Zhen
Abstract excerpt
Biallelic variants in SHMT2 cause neurodevelopmental disorders with cardiomyopathy, spasticity, and brain abnormalities (NEDCASB; OMIM: 619121). This recently described metabolic disorder are characterized by severe intellectual disability, microcephaly, spastic paraplegia, peripheral neuropathy, corpus callosum dysgenesis, facial and limb deformities, and progressive hypertrophic cardiomyopathy. Herein we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
